MC analysis of platelets from Glanzmann Thrombasthenia (GT) patients show a significant reduction in CD41, CD61, and activated integrin αIIbβ3 surface expression (84). This evidence concerns the gene ITGA2B and Glanzmann thrombasthenia 1.